Evidence map›Paper›PMID 12771993›Full record

ArticleBritish journal of cancer2003

In vivo evolution of tumour cells after the generation of double-strand DNA breaks.

H Mekid, O Tounekti, A Spatz, M Cemazar, F Z El Kebir, L M Mir

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Electrical Stimulation for Immune Modulation in Cancer Treatments.Frontiers in bioengineering and biotechnology · 2021
    Review
  5. Article
  6. Article
  7. CD4Clinical & experimental metastasis · 2016
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 5 countries.

H MekidVectorologie et transfert de gènes, UMR 8121 CNRS, Institut Gustave-Roussy, 39 rue C. Desmoulins, F-94805 Villejuif Cédex, France.
O Tounekti
A Spatz
M Cemazar
F Z El Kebir
L M Mir
Centre National de la Recherche Scientifique · FRInstitute of Oncology Ljubljana · SIInstitut Gustave Roussy · FRJewish General Hospital · CAUniversité Oran 1 Ahmed Ben Bella · DZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vitro, the ratio of single- to double-strand DNA breaks (DSB) and their absolute values determine the cell death pathway. The consequences of the generation of various numbers of DSB generated in vivo in tumour cells have been analysed in two different experimental tumour models. Synchronisation of DSB generation and control of their number have been achieved using different doses of bleomycin (BLM) and tumour cell permeabilisation by means of locally delivered electric pulses. According to BLM dose, different cell death pathways are observed. At a low therapeutic dose, a mitotic cell death pathway is detected. It is characterised by the appearance of 'atypical mitosis', TUNEL and caspase-3 positive, 24 h after the treatment, and later by the presence of typical apoptotic figures, mainly TUNEL positive but caspase-3 negative. Caspase-3 is thus an early marker of apoptosis. Mitotic cell death is also followed by lymphocytic infiltration reaction. At high doses of BLM, pseudoapoptosis is detected within a few minutes after the treatment. These cell death pathways are discussed as a function of the number of DSB generated, by comparison with previous results obtained in vitro using BLM or ionising radiation.

Indexed as

AnimalsApoptosisBleomycinCaspase 3CaspasesDNADNA DamageDNA, NeoplasmDNA RepairElectric StimulationImmunoenzyme TechniquesIn Situ Nick-End LabelingMelanoma, ExperimentalMiceMice, Inbred C57BLMicroscopy, ElectronBleomycinCasp3 protein, mouseCaspase 3CaspasesDNADNA, Neoplasm

Identifiers

PMID12771993
PMCPMC2377151
OpenAlexW2091924611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.